2.90

5.84% 0.16

Nuvation Bio Inc (NUVB)

Overview News Price History Option Chain Discussions Forecast

Nuvation Bio Inc stock is traded at $2.90, with a volume of 7.59M. It is up +5.84% in the last 24 hours and up +23.40% over the past month. Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Previous Close:

$2.74

Open:

$2.77

24h Volume:

7.59M

Relative Volume:

1.25

Market Cap:

$992.59M

Revenue:

Net Income/Loss:

$-75.80M

P/E Ratio:

-8.2857

EPS:

-0.35

Net Cash Flow:

$-68.07M

1W Performance:

+5.45%

1M Performance:

+23.40%

6M Performance:

+31.22%

1Y Performance:

+3.57%

1-Day Range:

$2.755

$2.98

1-Week Range:

$2.57

$2.98

52-Week Range:

$1.54

$3.455

Nuvation Bio Inc Stock (NUVB) Company Profile

Name

Nuvation Bio Inc

Sector

Healthcare (1157)

Industry

Biotechnology (645)

Phone

(415) 754-3517

Address

357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO

Employee

278

Twitter

Next Earnings Date

2025-03-05

Latest SEC Filings

NUVB's Discussions on Twitter

Compare NUVB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NUVB Nuvation Bio Inc	2.90	992.59M	0	-75.80M	-68.07M	-0.35
VRTX Vertex Pharmaceuticals Inc	395.12	99.96B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	589.48	60.83B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	454.38	59.89B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	660.00	40.47B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	313.67	37.96B	3.81B	-644.79M	-669.77M	-6.24

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-23-25	Initiated	Citizens JMP	Mkt Outperform
Mar-27-24	Upgrade	Jefferies	Hold → Buy
Mar-26-24	Upgrade	BTIG Research	Neutral → Buy
Jan-06-23	Downgrade	Jefferies	Buy → Hold
Aug-02-22	Downgrade	BMO Capital Markets	Outperform → Market Perform
Aug-02-22	Downgrade	BTIG Research	Buy → Neutral
May-04-22	Initiated	H.C. Wainwright	Buy
Oct-15-21	Resumed	BTIG Research	Buy
Apr-06-21	Initiated	RBC Capital Mkts	Outperform
Mar-08-21	Initiated	BMO Capital Markets	Outperform
Mar-08-21	Initiated	BTIG Research	Buy
Mar-08-21	Initiated	Cowen	Outperform
Mar-08-21	Initiated	Jefferies	Buy
Mar-08-21	Initiated	Wedbush	Outperform

View All

Nuvation Bio Inc Stock (NUVB) Latest News

Aug 19, 2025

Nuvation Bio Inc. shares fall 1.07% after-hours following multiple analyst presentations. - AInvest

Aug 19, 2025

Nuvation Bio (NUVB.N) Plummets 5.3%: What’s Driving the Sudden Downturn? - AInvest

Aug 19, 2025

Transcript : Nuvation Bio Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 01 - MarketScreener

Aug 19, 2025

Transcript : Nuvation Bio Inc.Special Call - MarketScreener

Aug 19, 2025

Aug 17, 2025

Nuvation Bio Inc. Could See a Relief Rally From SupportPortfolio Value Report & Consistent Profit Focused Trading Strategies - newsyoung.net

Aug 17, 2025

Aug 16, 2025

Why Nuvation Bio Inc. stock attracts strong analyst attentionJuly 2025 Gainers & Verified High Yield Trade Plans - thegnnews.com

Aug 16, 2025

Aug 15, 2025

Detecting support and resistance levels for Nuvation Bio Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser

Aug 15, 2025

What institutional flow reveals about Nuvation Bio Inc.Portfolio Value Report & Low Drawdown Trading Strategies - Newser

Aug 15, 2025

Nuvation Bio Inc. stock outlook for YEARLayoff News & Growth Focused Stock Reports - Newser

Aug 15, 2025

XTX Topco Ltd Buys 44,979 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Aug 15, 2025

What MACD signals say about Nuvation Bio Inc.July 2025 Price Swings & Capital Efficient Trade Techniques - Newser

Aug 15, 2025

Does Nuvation Bio Inc. show high probability of reboundJuly 2025 Patterns & Verified Chart Pattern Trade Signals - Newser

Aug 15, 2025

Nuvation Bio's Breakthrough FDA-Approved Iprozy and Its Implications for Biotech Growth - AInvest

Aug 15, 2025

Aug 14, 2025

Transcript : Nuvation Bio Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 14, 2025

Exit strategy if you’re trapped in Nuvation Bio Inc.Volume Spike & Fast Exit Strategy with Risk Control - Newser

Aug 14, 2025

Nuvation Bio’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Nigeria

Aug 14, 2025

Chart Patterns Forming a Bullish Setup in Nuvation Bio Inc.2025 Valuation Update & Reliable Price Breakout Signals - kangso.co.kr

Aug 14, 2025

Nuvation Bio’s SWOT analysis: stock poised for growth amid challenges - Investing.com

Aug 14, 2025

Technical analysis overview for Nuvation Bio Inc. stockPortfolio Risk Summary & Daily Volume Surge Signals - Newser

Aug 14, 2025

Aug 13, 2025

Nuvation Bio (NUVB.N) Spikes 11.6% Intraday: A Deep Dive Into the Unusual Move - AInvest

Aug 13, 2025

Nuvation Bio (NUVB.N) Surges 12.5%—What’s Fueling the Move? - AInvest

Aug 13, 2025

Analyzing recovery setups for Nuvation Bio Inc. investorsCEO Change & Free Community Consensus Stock Picks - Newser

Aug 13, 2025

Aug 11, 2025

Tools to monitor Nuvation Bio Inc. recovery probabilityChart Pattern Strategy with ROI Focus - Newser

Aug 11, 2025

Aug 10, 2025

Nuvation Bio Inc. (NYSE:NUVB) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - 富途牛牛

Aug 10, 2025

Nuvation Bio (NYSE:NUVB) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - Defense World

Aug 10, 2025

Aug 09, 2025